• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of COVID-19 atypical pneumonia by early Tocilizumab administration in "non-critically-ill" patients on hemodialysis.

作者信息

Castellano Giuseppe, Infante Barbara, Mercuri Silvia, Forcella Mauro, Cox Sharon Natasha, Serviddio Gaetano, Gesualdo Loreto, Stallone Giovanni

机构信息

Department of Medical and Surgical Sciences, Nephrology, Dialysis and Transplantation Unit, University of Foggia, Viale Luigi Pinto, 1, 71100, Foggia, Italy.

Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari "Aldo Moro", Bari, Italy.

出版信息

J Nephrol. 2021 Feb;34(1):259-262. doi: 10.1007/s40620-020-00872-4. Epub 2020 Sep 30.

DOI:10.1007/s40620-020-00872-4
PMID:32997331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7525227/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/7525227/89f7cf62c174/40620_2020_872_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/7525227/427258be72c9/40620_2020_872_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/7525227/89f7cf62c174/40620_2020_872_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/7525227/427258be72c9/40620_2020_872_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/7525227/89f7cf62c174/40620_2020_872_Fig2_HTML.jpg

相似文献

1
Treatment of COVID-19 atypical pneumonia by early Tocilizumab administration in "non-critically-ill" patients on hemodialysis.在接受血液透析的“非重症”患者中早期使用托珠单抗治疗新型冠状病毒肺炎非典型肺炎
J Nephrol. 2021 Feb;34(1):259-262. doi: 10.1007/s40620-020-00872-4. Epub 2020 Sep 30.
2
Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients.托珠单抗联合激素脉冲疗法治疗 HD 患者危重型 COVID-19 的临床疗效及安全性。
Clin Exp Nephrol. 2022 Jan;26(1):75-85. doi: 10.1007/s10157-021-02126-4. Epub 2021 Aug 26.
3
Effective treatment with Tocilizumab in a COVID-19 patient on maintenance hemodialysis: A case report.托珠单抗治疗维持性血液透析 COVID-19 患者的疗效：一例报告。
CEN Case Rep. 2021 Aug;10(3):364-369. doi: 10.1007/s13730-021-00577-y. Epub 2021 Jan 27.
4
A retrospective evaluation of COVID-19 patients treated with Tocilizumab: who should be treated?托珠单抗治疗 COVID-19 患者的回顾性评估：谁应该接受治疗？
J Infect Dev Ctries. 2021 Dec 31;15(12):1825-1832. doi: 10.3855/jidc.13498.
5
The Importance of the Timing of Tocilizumab Administration in Moderate to Severely Ill COVID-19: Single Centered Experience Case series.托珠单抗给药时机对中重度 COVID-19 患者的重要性：单中心经验病例系列。
Acta Med Indones. 2021 Jul;53(3):319-325.
6
Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab.使用托珠单抗治疗后COVID-19肺炎的快速影像学改善。
Infection. 2021 Feb;49(1):195-196. doi: 10.1007/s15010-020-01449-w. Epub 2020 Jun 15.
7
Single dose of subcutaneous tocilizumab in COVID-pneumonia: CT evidence of lymph nodal and parenchymal response.COVID-19肺炎患者皮下注射单剂量托珠单抗：淋巴结及实质反应的CT证据
J Med Virol. 2021 Feb;93(2):599-600. doi: 10.1002/jmv.26345. Epub 2020 Aug 13.
8
Identification of Complex Pneumonia during the Outbreak of COVID-19: Bacterial Pneumonia Combined with Acute Eosinophilic Pneumonia in Patients with Maintenance Hemodialysis.在 COVID-19 爆发期间识别复杂肺炎：维持性血液透析患者中细菌肺炎合并急性嗜酸性肺炎。
Blood Purif. 2021;50(1):132-136. doi: 10.1159/000509789. Epub 2020 Jul 28.
9
Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management.早期使用托珠单抗预防 SARS-CoV-2 感染所致成人呼吸衰竭及白细胞介素-6 水平在管理中的应用。
J Med Virol. 2021 Jan;93(1):491-498. doi: 10.1002/jmv.26288. Epub 2020 Jul 15.
10
Tocilizumab for the Critically Ill With Severe COVID-19: A Community Hospital Case Series.托珠单抗治疗重症 COVID-19 患者：社区医院病例系列研究。
J Pharm Pract. 2022 Aug;35(4):587-592. doi: 10.1177/08971900211002353. Epub 2021 Mar 19.

引用本文的文献

1
Case Report: Tocilizumab for Acute Kidney Graft Dysfunction in Patient Affected by COVID-19.病例报告：托珠单抗治疗新冠病毒感染患者的急性肾移植功能障碍
Front Med (Lausanne). 2021 Nov 25;8:732792. doi: 10.3389/fmed.2021.732792. eCollection 2021.

本文引用的文献

1
Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19.托珠单抗的严重不良事件：药物警戒作为 COVID-19 监测重点的辅助手段。
Br J Clin Pharmacol. 2021 Mar;87(3):1533-1540. doi: 10.1111/bcp.14459. Epub 2020 Jul 26.
2
Case series of six kidney transplanted patients with COVID-19 pneumonia treated with tocilizumab.COVID-19 肺炎致 6 例肾移植术后患者采用托珠单抗治疗的病例系列研究。
Transpl Infect Dis. 2020 Dec;22(6):e13348. doi: 10.1111/tid.13348. Epub 2020 Jun 17.
3
Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case report.
肝移植术后血液透析患者 COVID-19 的临床病程及托珠单抗治疗的反应：一例报告。
Am J Transplant. 2020 Aug;20(8):2254-2259. doi: 10.1111/ajt.15985. Epub 2020 Jun 3.
4
Effective treatment of severe COVID-19 patients with tocilizumab.托珠单抗治疗重症 COVID-19 患者有效。
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29.
5
Mild or Moderate Covid-19.轻度或中度新冠病毒感染
N Engl J Med. 2020 Oct 29;383(18):1757-1766. doi: 10.1056/NEJMcp2009249. Epub 2020 Apr 24.
6
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.武汉成人 COVID-19 住院患者严重程度和死亡率的危险因素。
J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12.
7
A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease.慢性血液透析患者以肠炎起病并发展为重症肺部疾病的新型冠状病毒病 19 例。
Am J Nephrol. 2020;51(5):337-342. doi: 10.1159/000507417. Epub 2020 Mar 28.
8
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
9
Significance of frailty among dialysis patients.透析患者中衰弱的意义。
J Am Soc Nephrol. 2007 Nov;18(11):2960-7. doi: 10.1681/ASN.2007020221. Epub 2007 Oct 17.